Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,920 | -$30,944 | -$28,730 | -$21,194 |
| Dep. & Amort. | $315 | $346 | $300 | $307 |
| Deferred Tax | $0 | $0 | $0 | $114 |
| Stock-Based Comp. | $694 | $2,450 | $1,297 | $1,487 |
| Change in WC | -$4,598 | $3,244 | $4,766 | -$1,761 |
| Other Non-Cash | $6,538 | $1,098 | -$626 | -$1,171 |
| Operating Cash Flow | -$22,971 | -$23,806 | -$22,993 | -$22,218 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$123 | -$385 | -$474 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$225 | $0 | -$0 | $1 |
| Investing Cash Flow | -$226 | -$123 | -$385 | -$473 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$171 | -$797 | $10,284 | $540 |
| Stock Issued | $31,850 | $26,031 | $13,445 | $25,559 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,863 | -$1,251 | -$251 | -$509 |
| Financing Cash Flow | $25,816 | $23,983 | $23,478 | $25,590 |
| Forex Effect | $8 | -$168 | $37 | -$153 |
| Net Chg. in Cash | $2,627 | -$114 | $137 | $2,745 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,876 | $6,990 | $6,853 | $4,108 |
| End Cash | $9,503 | $6,876 | $6,990 | $6,853 |
| Free Cash Flow | -$23,197 | -$23,929 | -$23,378 | -$22,692 |